Inogen (INGN) EBT Margin Growth (1y) (2014 - 2026)
Inogen (INGN) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 165.00 |
| 10 | Inogen | 151.45 Mn | 45.91 Mn | 43.27 Mn | 45.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 |
| Mar 31, 2026 | -236.00 |
| Dec 31, 2025 | 1,533.00 |
| Sep 30, 2025 | 94.00 |
| Jun 30, 2025 | 164.00 |
| Mar 31, 2025 | 1,125.00 |
| Dec 31, 2024 | -9,821.00 |
| Sep 30, 2024 | 4,714.00 |
| Jun 30, 2024 | 539.00 |
| Mar 31, 2024 | 905.00 |
| Dec 31, 2023 | 15,887.00 |
| Sep 30, 2023 | -4,502.00 |
| Jun 30, 2023 | -844.00 |
| Mar 31, 2023 | -1,052.00 |
| Dec 31, 2022 | -5,782.00 |
| Sep 30, 2022 | -1,628.00 |
| Jun 30, 2022 | -1,508.00 |
| Mar 31, 2022 | -1,466.00 |
| Dec 31, 2021 | 75.00 |
| Sep 30, 2021 | 1,019.00 |